(NASDAQ: NUWE) Nuwellis's forecast annual revenue growth rate of 61.85% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.24%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.54%.
Nuwellis's revenue in 2026 is $9,013,000.On average, 3 Wall Street analysts forecast NUWE's revenue for 2026 to be $36,709,712, with the lowest NUWE revenue forecast at $35,272,690, and the highest NUWE revenue forecast at $37,789,302. On average, 3 Wall Street analysts forecast NUWE's revenue for 2027 to be $41,119,254, with the lowest NUWE revenue forecast at $39,507,164, and the highest NUWE revenue forecast at $42,330,146.
In 2028, NUWE is forecast to generate $158,134,425 in revenue, with the lowest revenue forecast at $151,934,076 and the highest revenue forecast at $162,784,687.